Company profilePharmaceutical#479 of 1,318 in Pakistan✓ No DRAP alerts

DERMAGEN PHARMA PAKISTAN (PVT) LIMITED

Pharmaceutical company · 29 brands · 36 molecules

Ranked #4 of 42 companies in Corticosteroid Combinations, Topical

29 registered products 25 pharmaceutical brands 36 distinct molecules 0 DRAP alerts

Company overview

29
registered products
25
pharmaceutical brands
36
distinct molecules
12
therapeutic classes
0
DRAP alerts

DERMAGEN PHARMA PAKISTAN (PVT) LIMITED is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 29 product registrations across 36 distinct molecules. Its portfolio is concentrated in Corticosteroid Combinations, Topical and Anti-Acne Preparations. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by DERMAGEN

5 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Skin Conditions 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

2
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20252

Top molecules by brand count

Clobetasol3 brands
Fusidic Acid3 brands
Zinc Oxide2 brands
Isotretinoin2 brands
Permethrin2 brands
Sulphur2 brands
Tretinoin2 brands
Hydroquinone2 brands

Therapeutic classes

Corticosteroid Combinations, Topical · 6Anti-Acne Preparations · 6Anti-Infectives · 2Skin Conditions · 2Tetracyclines · 1Antimycotics Systemic Use · 1Allergy · 1Antipsoriatics · 1Corticosteroid, Plain · 1Antibiotics For Topical Use · 1Other Beta-Lactam, Cephalosporins & Penems · 1Macrolides, Lincosamides And Streptogramins · 1

Conditions treated

Fungal Infection · 2Non-Sedative Agents · 1Acne/Topical · 1Eczema/Psoriasis/Dermatitis · 1Warts · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official2 products · Rs 144.3 – Rs 488.85
DVAGO1 products · Rs 149.06 – Rs 149.06
Servaid7 products · Rs 104.36 – Rs 358
Median across source: Rs 200

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.22 shared molecules
VALOR PHARMACEUTICALS22 shared molecules
PEARL PHARMACEUTICALS20 shared molecules
SHROOQ PHARMACEUTICALS17 shared molecules
DERMA TECHNO PAKISTAN16 shared molecules
Albro Pharmaceuticals15 shared molecules
Sante (Private) Limited14 shared molecules
NEUTRO PHARMA (PVT) LTD.14 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 138 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
VALOR PHARMACEUTICALS holds 157 molecules not in this portfolio
000 I.UAcetylcysteineAcitretinAcyclovirAdapaleneAdaplene
PEARL PHARMACEUTICALS holds 68 molecules not in this portfolio
AcitretinAcyclovirAmlodipineArtemetherArtemether LumefantrineAscorbic Acid

Get the full profile for DERMAGEN

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.